Literature DB >> 33104905

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy.

Felix Behling1,2,3, Christina Fodi4,5,6, Elgin Hoffmann5,6,7, Mirjam Renovanz4,5,6,8, Marco Skardelly4,5,6, Ghazaleh Tabatabai4,5,6,8,9,10, Jens Schittenhelm6,11, Jürgen Honegger4,5,6, Marcos Tatagiba4,5,6.   

Abstract

Since the introduction of the Simpson grading for the extent of resection in meningiomas in 1957, its usefulness in modern neurosurgery has been challenged. Especially, the updated WHO classification regarding brain invasion and the efficacy of radiation therapy has not been taken into account when evaluating the prognostic role of the Simpson grading in this era. We analyzed the clinical and histopathological data of 1571 meningiomas that were surgically resected in the authors' institution between July 2003 and March 2017. Operative reports were reviewed regarding the extent of resection according to Simpson grading. Meningioma subtype according to the updated WHO classification of 2016 and clinical characteristics and time to tumor progression were analyzed. The mean follow-up was 38.4 months (range 1.2 to 195.6). A higher rate of tumor recurrence was observed for male gender, younger age, recurrent tumors, non-spinal tumor localization, higher WHO, and Simpson grades in the univariate analysis. In the multivariate analysis older age, recurrent tumors and higher WHO grades remained negative prognostic factors. Among the different Simpson grades, the relative risk for recurrence was highest for grade IV compared to all other grades (each p < 0.0001), while there was no difference between Simpson grades I and II. Adjuvant radiotherapy showed lower rates of tumor recurrence. Subtotal microsurgical resection remains an independent prognostic factor with a higher rate of tumor recurrence. The prognostic benefit of radical treatment of the dural attachment is questionable and needs to be considered when weighing the intraoperative risks of radicality.
© 2020. The Author(s).

Entities:  

Keywords:  Meningioma; Prognosis; Progression-free survival; Radiotherapy; Recurrence; Simpson grading

Year:  2020        PMID: 33104905     DOI: 10.1007/s10143-020-01428-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  13 in total

1.  Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.

Authors:  Anil Nanda; Shyamal C Bir; Tanmoy K Maiti; Subhas K Konar; Symeon Missios; Bharat Guthikonda
Journal:  J Neurosurg       Date:  2016-04-08       Impact factor: 5.115

2.  Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.

Authors:  Leland Rogers; Peixin Zhang; Michael A Vogelbaum; Minesh P Mehta
Journal:  J Neurosurg       Date:  2018-12-01       Impact factor: 5.115

3.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Authors:  Soichi Oya; Kensuke Kawai; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Neurosurg       Date:  2012-05-04       Impact factor: 5.115

4.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

5.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.

Authors:  Quinn T Ostrom; Gino Cioffi; Haley Gittleman; Nirav Patil; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2019-11-01       Impact factor: 12.300

6.  Meningioma: analysis of recurrence and progression following neurosurgical resection.

Authors:  R O Mirimanoff; D E Dosoretz; R M Linggood; R G Ojemann; R L Martuza
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

7.  The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.

Authors:  Konstantinos Gousias; Johannes Schramm; Matthias Simon
Journal:  J Neurosurg       Date:  2016-01-29       Impact factor: 5.115

Review 8.  The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.

Authors:  Arash Motekallemi; Hanne-Rinck Jeltema; Jan D M Metzemaekers; Gooitzen M van Dam; Lucy M A Crane; Rob J M Groen
Journal:  Neurosurg Rev       Date:  2015-03-05       Impact factor: 3.042

Review 9.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

10.  Benefits of re-do surgery for recurrent intracranial meningiomas.

Authors:  Jean-Michel Lemée; Marco V Corniola; Torstein R Meling
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

View more
  2 in total

1.  The prognostic role of the immunohistochemical expression of S100 in meningiomas.

Authors:  Felix Behling; Christina Fodi; Marco Skardelly; Frank Paulsen; Ghazaleh Tabatabai; Jürgen Honegger; Marcos Tatagiba; Jens Schittenhelm
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-15       Impact factor: 4.322

Review 2.  The Simpson Grading: Is It Still Valid?

Authors:  Silky Chotai; Theodore H Schwartz
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.